Yutaka Shimazu. "Optimizing Allogeneic Chimeric Antigen Receptor T-Cell Persistence in Relapsed/Refractory Large B-Cell Lymphoma: The Role of KIR Matching." Journal of Clinical Oncology, 2025. doi:10.1200/jco-25-00394